In an era when Europe seeks greater technological sovereignty, even medical innovations can become strategic assets. Interact Medical Technologies, Inc. exemplifies this intersection of healthcare and defense interests. Born from cutting-edge robotics research, this company develops intelligent exoskeletons and remote monitoring devices that restore mobility to patients with neurological injuries. Its solutions do more than heal – they also align with Europe’s drive to reduce reliance on non-allied suppliers. Though incorporated in the United States, Interact’s roots lie in a leading Turkish research university, reflecting a blend of transatlantic innovation and NATO-aligned collaboration. The company’s AI-guided rehabilitation systems hint at a future where advanced medical technology bolsters both public health and military resilience, a prospect that has drawn the attention of NATO’s innovation arms and European stakeholders alike. This compelling dual-use profile invites a closer look at how Interact’s approach to medical robotics may quietly reinforce European strategic autonomy.